Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Investor's Business Daily
The Administration’s Flu Fear-Mongering
‘In keeping with the administration’s proactive approach” to swine flu, the White House has announced that President Obama has declared the disease “a national emergency.”…
Newsletter
Health Care Competition, Financial Regulations in Court and Net Neutrality
The House Judiciary Committee votes to strip antitrust protections from health insurance companies who share risk information. Prominent officials and scholars endorse CEI’s Supreme Court…
Study
A Cure Worse than the Disease
Obama Care Won’t Cut Costs, But May Cut Quality…
News Release
New Report: Finance Committee Health Care Bill is a Cure Worse than the Disease
New Report: Finance Committee Health Care Bill is a Cure Worse than the Disease Baucus Proposal Won’t Cut Costs, But May Cut Quality…
News Release
Repeal of Insurance Antitrust Exemption Threatens Competition
Repeal of Insurance Antitrust Exemption Threatens Competition Patients Brace for Higher Prices, Raw Deal Washington, D.C., October 21, 2009—The House Judiciary Committee voted on…
Investor's Business Daily